In addition, the tracer F18-AV1451 successfully discriminated tau pathology levels between normal and MCI patients, as well as between MCI and AD patients (Brier et al., 2016; Leuzy et al., 2019; Passamonti et al., 2017). The gene discussed is MAPT; the disease is Alzheimer disease.